small medium large |  
print   |   Bookmark & Share share


Program Duration: 1–3 years

stroke1 stroke2 stroke3 stroke4

Above: Diffusion-perfusion mismatch; panels one and two display a lack of perfusion, panels three and four are following reperfusion

With a focus on clinical practice and research, the ACGME-accredited Vascular Neurology Fellowship at the NIH/NINDS Stroke Program is designed for neurologists who seek to become experts in the management of cerebrovascular disorders. The program is oriented toward emergency management of stroke with emphasis in neuroimaging, thrombolysis, and other novel therapeutic and diagnostic approaches. The program offers a one-year ACGME accredited fellowship with the opportunity to extend the fellowship for a research-focused second (and possibly third) non-ACGME accredited year for those interested in an academic or research track.

The clinical and research activities of the NIH Stroke Program take place at the NIH Clinical Center, Suburban Hospital (a 239-bed community hospital and a member of Johns Hopkins Medicine located directly across from the NIH Campus), and Washington Hospital Center (a 926-bed academic medical center located in Washington, DC). This unique program design orients the Fellow to the role of vascular neurology in both academic and community hospital settings while providing access to greater diversity in disease etiology.

The clinical research seeks to make scientific advances toward new stroke therapies by developing, validating and testing imaging markers for use in clinical trials and practice. The overall approach is to: (1) investigate early pathobiological events in the evolving lesion in human stroke; (2) identify candidate imaging biomarkers of disease mechanisms or progression that are linked to clinical outcomes and therapeutic efficacy; and (3) use these markers as a basis for innovative clinical trial designs of novel therapeutic approaches in Phase II "proof of principle" trials. 

Area of Current Research

MRI-guided enhancement of diagnosis and management of Acute Stroke
Supplementary measures to augment the efficacy, safety, and appropriate use of tPA and endovascular treatments


Clinton Wright, M.D., Acting Chief, Stroke Branch,

Richard Benson, M.D., Ph.D., Associate Medical Director, Washington Hospital Center, Stroke Center,

Amie Hsia, M.D., Medical Director, Washington Hospital Center, Stroke Center,

Lawrence Latour, Ph.D., Senior Scientist, Stroke Diagnostics and Therapeutics Section,

Richard Leigh, M.D., Assistant Clinical Investigator, Neuro Vascular Brain Imaging Unit,

John Lynch, D.O., M.P.H., Staff Clinician and Fellowship Program Director, Stroke Diagnostics and Therapeutics Section,

Christine Turtzo, M.D., Staff Clinician, Stroke  Branch,